Core Viewpoint - The company has decided to deregister its subsidiary, Yuhe Financial Services Co., Ltd., due to changes in financial regulations that have rendered its original business model unsustainable [2][3]. Group 1: Company Decision - The company announced the decision to deregister Yuhe Financial, in which it holds a 20% stake with an investment of 10 million yuan [1]. - Yuhe Financial was established in June 2016 and primarily served small and medium-sized enterprises in Xianju County [1]. Group 2: Impact of Financial Policy Changes - The original business operations of Yuhe Financial, focused on loan turnover for small and medium enterprises, have ceased due to ongoing adjustments in financial regulatory policies [2]. - Regulatory authorities have mandated that Yuhe Financial either change its business scope or cease operations, leading to the decision for dissolution and liquidation [2]. Group 3: Operational Independence - The company clarified that it has not provided any guarantees, financial support, or entrusted financial services to Yuhe Financial, indicating a low level of operational interdependence [4]. - The deregistration will not affect the company's main business operations, which focus on the research, production, and sales of steroid raw materials and formulations across four major categories: corticosteroids, sex hormones, anesthetics, and respiratory drugs [4]. - The deregistration process does not involve any personnel placement issues and will not impact the company's ongoing profitability [4].